Opendoor Technologies is facing a pivotal moment as it battles a U.S. housing market that the CEO described as "very ...

Novo Nordisk A/S (NYSE: NVO) is one of the top oversold NYSE stocks to buy now. In a report released on August 4, Emily Field from Barclays maintained a Hold rating on Novo Nordisk A/S (NYSE:NVO), ...

HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Astera Labs soars 143% in Q2 2025, boosted by AI tech growth and key partnerships despite Russell index removal risk.

When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Serve Robotics SERV is set to report second-quarter 2025 results on Aug. 7. In the last reported quarter, the company’s ...